Gilead Sciences Inc Competitors
Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
---|---|---|---|---|---|---|---|---|
ABBV | AbbVie | Outperform |
9
|
$161.72 | $178.42 | 15.01% | 11 | $286.35B |
AMGN | Amgen | Outperform |
4
|
$277.37 | $303.65 | 15.19% | 8 | $148.77B |
ALXN | Alexion Pharmaceuticals | - |
0
|
$182.50 | $177.38 | -100.00% | 0 | $40.34B |
BIIB | Biogen | Outperform |
10
|
$216.13 | $299.62 | 33.48% | 13 | $31.47B |
BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$83.33 | $111.56 | 32.01% | 5 | $15.82B |
INCY | Incyte | Outperform |
9
|
$52.94 | $77.05 | 45.83% | 8 | $11.89B |
VKTX | Viking Therapeutics | Buy |
5
|
$76.43 | $34.00 | 50.46% | 6 | $8.78B |
EXEL | Exelixis | Outperform |
16
|
$21.93 | $26.44 | 23.12% | 5 | $6.92B |
ARNA | Arena Pharmaceuticals | - |
6
|
$99.99 | $100.00 | -100.00% | 0 | $6.17B |
BPMC | Blueprint Medicines | Outperform |
6
|
$94.86 | $85.71 | 5.42% | 5 | $5.74B |
CCXI | ChemoCentryx | - |
8
|
$51.99 | $52.00 | -100.00% | 0 | $3.74B |
CBAY | CymaBay Therapeutics | - |
8
|
$32.44 | $27.73 | -100.00% | 5 | $3.72B |
IOVA | Iovance Biotherapeutics | Buy |
4
|
$12.50 | $20.42 | 104.00% | 4 | $3.30B |
DRNA | Dicerna Pharmaceuticals | - |
7
|
$38.01 | $35.06 | -100.00% | 0 | $2.99B |
FOLD | Amicus Therapeutics | Outperform |
7
|
$10.43 | $17.90 | 91.75% | 1 | $2.96B |
ARWR | Arrowhead Pharmaceuticals | Outperform |
7
|
$23.17 | $52.00 | 128.74% | 0 | $2.80B |
ACAD | ACADIA Pharmaceuticals | Outperform |
6
|
$17.05 | $33.78 | 75.07% | 6 | $2.76B |
CLDX | Celldex Therapeutics | Buy |
11
|
$39.35 | $63.29 | 95.68% | 1 | $2.47B |
VCEL | Vericel | Buy |
8
|
$47.08 | $42.58 | 16.82% | 0 | $2.22B |
AGIO | Agios Pharmaceuticals | Outperform |
9
|
$33.66 | $40.00 | 29.23% | 4 | $1.85B |
ADMA | ADMA Biologics | Buy |
9
|
$6.67 | $6.00 | 19.94% | 0 | $1.51B |
ARDX | Ardelyx | Buy |
11
|
$6.61 | $9.94 | 104.24% | 5 | $1.50B |
DVAX | Dynavax Technologies | Outperform |
11
|
$11.68 | $25.00 | 109.76% | 1 | $1.49B |
XNCR | Xencor | Outperform |
6
|
$23.93 | $37.91 | 42.08% | 4 | $1.29B |
MNKD | MannKind | Buy |
10
|
$4.34 | $6.92 | 55.53% | 1 | $1.11B |
CATX | Perspective Therapeutics | Buy |
9
|
$1.70 | $1.20 | -11.76% | 0 | $986.02M |
BCRX | BioCryst Pharmaceuticals | Outperform |
7
|
$4.57 | $14.09 | 129.76% | 2 | $852.15M |
SAGE | Sage Therapeutics | Hold |
6
|
$13.28 | $25.28 | 43.07% | 2 | $838.94M |
BLFS | BioLife Solutions | Buy |
9
|
$17.48 | $22.57 | 23.00% | 1 | $794.56M |
OCUL | Ocular Therapeutix | Outperform |
6
|
$5.02 | $12.25 | 198.80% | 3 | $733.40M |
ABUS | Arbutus Biopharma | Outperform |
9
|
$2.69 | $6.34 | 101.86% | 0 | $491.88M |
RDUS | Radius Health | - |
4
|
$10.08 | $10.00 | -100.00% | 0 | $485.05M |
FATE | Fate Therapeutics | Outperform |
7
|
$4.09 | $6.23 | 71.15% | 14 | $449.58M |
TVTX | Travere Therapeutics | Outperform |
8
|
$6.00 | $14.07 | 141.67% | 5 | $420.88M |
CRBP | Corbus Pharmaceuticals Holding... | Buy |
6
|
$37.25 | $20.00 | 47.65% | 3 | $389.19M |
ANIK | Anika Therapeutics | Outperform |
10
|
$26.49 | $27.33 | 20.80% | 2 | $379.60M |
RVNC | Revance Therapeutics | Outperform |
6
|
$3.80 | $26.92 | 268.42% | 5 | $376.22M |
AERI | Aerie Pharmaceuticals | - |
7
|
$0.73 | $15.25 | -100.00% | 0 | $358.35M |
HRTX | Heron Therapeutics | Buy |
7
|
$2.34 | $5.63 | 177.78% | 0 | $349.48M |
CERS | Cerus | Outperform |
6
|
$1.72 | $4.13 | 190.70% | 1 | $308.77M |
PFNX | Pfenex | - |
2
|
$0.00 | $13.00 | 0.00% | 0 | $301.67M |
CNCE | Concert Pharmaceuticals | - |
6
|
$8.37 | $17.00 | -100.00% | 0 | $293.84M |
ENTA | Enanta Pharmaceuticals | Outperform |
10
|
$13.56 | $23.88 | 47.49% | 2 | $290.68M |
CRMD | CorMedix | Outperform |
10
|
$5.52 | $14.25 | 117.39% | 0 | $288.93M |
VNDA | Vanda Pharmaceuticals | - |
0
|
$4.77 | $4.25 | 9.22% | 0 | $277.02M |
AKBA | Akebia Therapeutics | Outperform |
8
|
$1.24 | $4.33 | 303.23% | 2 | $263.81M |
EPZM | Epizyme | - |
6
|
$1.47 | $6.00 | -100.00% | 0 | $255.91M |
STML | Stemline Therapeutics | - |
7
|
$169.15 | $12.50 | -100.00% | 0 | $229.28M |
CHRS | Coherus BioSciences | Outperform |
6
|
$2.06 | $10.86 | 288.35% | 3 | $222.46M |
ADRO | Aduro Biotech | - |
6
|
$2.59k | $18.75 | -100.00% | 0 | $221.28M |
ALDX | Aldeyra Therapeutics | Buy |
7
|
$4.20 | $9.40 | 138.10% | 0 | $211.76M |
CLVS.Q | Clovis Oncology | - |
6
|
$0.02 | $1.50 | -100.00% | 0 | $208.62M |
ABEO | Abeona Therapeutics | Buy |
8
|
$3.91 | $21.25 | 334.78% | 2 | $207.08M |
CDXS | Codexis | Buy |
6
|
$3.11 | $5.83 | 60.77% | 3 | $198.96M |
OMER | Omeros | Hold |
11
|
$3.40 | $13.00 | -100.00% | 2 | $182.52M |
BLUE | bluebird bio | Hold |
6
|
$0.91 | $7.20 | 339.56% | 2 | $170.98M |
XOMA | XOMA | Outperform |
2
|
$23.13 | $74.00 | 219.93% | 0 | $169.90M |
LJPC | La Jolla Pharmaceutical | - |
11
|
$6.22 | $6.23 | -100.00% | 0 | $154.54M |
RGLS | Regulus Therapeutics | Outperform |
10
|
$2.51 | $7.67 | 198.80% | 3 | $139.44M |
ORMP | Oramed Pharmaceuticals | Hold |
8
|
$2.34 | $4.30 | 81.62% | 0 | $126.66M |
GLYC | GlycoMimetics | Buy |
10
|
$1.62 | $7.67 | 393.83% | 1 | $124.07M |
DMAC | DiaMedica Therapeutics | Buy |
2
|
$2.59 | $8.33 | 170.27% | 0 | $116.14M |
CLRB | Cellectar Biosciences | Buy |
6
|
$3.16 | $12.00 | 295.57% | 1 | $114.80M |
LIFE | aTyr Pharma | Outperform |
10
|
$1.59 | $26.00 | 1157.86% | 2 | $93.11M |
MNOV | MediciNova | Buy |
4
|
$1.50 | $16.50 | 1000.00% | 0 | $80.44M |
ATRA | Atara Biotherapeutics | Hold |
5
|
$0.68 | $4.83 | 142.65% | 3 | $79.30M |
CMRX | Chimerix | Buy |
10
|
$0.95 | $7.33 | 636.84% | 4 | $85.15M |
MRNS | Marinus Pharmaceuticals | Outperform |
6
|
$1.47 | $20.30 | 308.16% | 1 | $77.44M |
ASMB | Assembly Biosciences | Outperform |
11
|
$13.27 | $3.00 | 171.29% | 2 | $73.52M |
CDTX | Cidara Therapeutics | Buy |
6
|
$11.81 | $4.67 | 111.69% | 1 | $61.71M |
PTN | Palatin Technologies | Buy |
4
|
$1.87 | $43.00 | 220.86% | 0 | $56.60M |
SCYX | SCYNEXIS | Buy |
6
|
$1.72 | $7.13 | 292.44% | 2 | $54.37M |
CARA | Cara Therapeutics | Outperform |
6
|
$0.76 | $12.14 | 557.89% | 0 | $49.58M |
BCLI | Brainstorm Cell Therapeutics | Hold |
4
|
$0.43 | $0.50 | 481.40% | 0 | $36.36M |
V9Z | Aceragen | - |
7
|
0.47€ | 1.00€ | -100.00% | 0 | 25.39€M |
LSTA | Lisata Therapeutics | Buy |
8
|
$2.85 | $16.00 | 408.77% | 2 | $23.85M |
AYTU | Aytu BioPharma | Outperform |
9
|
$2.89 | $5.00 | 176.82% | 0 | $17.54M |
NERV | Minerva Neurosciences | Hold |
4
|
$2.40 | $11.00 | 358.33% | 1 | $17.34M |
ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |
PIRS | Pieris Pharmaceuticals | - |
9
|
$11.68 | $7.00 | -100.00% | 0 | $14.35M |
TRVN | Trevena | Outperform |
2
|
$0.61 | $5.18 | 555.74% | 0 | $9.38M |
HEPA | Hepion Pharmaceuticals | Outperform |
7
|
$1.36 | $30.00 | 2105.88% | 0 | $7.50M |
TENX | Tenax Therapeutics | Outperform |
4
|
$3.90 | $5.50 | 733.33% | 1 | $7.11M |
PSTV | Plus Therapeutics | Outperform |
11
|
$1.72 | $11.00 | 772.09% | 2 | $7.35M |
XBIO | Xenetic Biosciences | Hold |
8
|
$3.85 | $4.00 | 4.68% | 0 | $5.98M |
NHWK | NightHawk Biosciences | Hold |
8
|
$0.18 | $10.00 | 5455.56% | 0 | $5.66M |
TCON | TRACON Pharmaceuticals | Outperform |
9
|
$1.71 | $4.00 | 2092.98% | 0 | $4.46M |
BPTH | Bio-Path Holdings | Outperform |
5
|
$2.76 | $12.00 | 1349.28% | 1 | $3.96M |
CYCC | Cyclacel Pharmaceuticals | Outperform |
5
|
$2.65 | $240.00 | 6050.94% | 0 | $3.49M |
RKDA | Arcadia Biosciences | Buy |
8
|
$2.54 | $15.00 | 333.07% | 0 | $3.18M |
ARAV | Aravive | - |
10
|
$0.04 | $0.25 | -100.00% | 0 | $2.95M |
ADXS | Advaxis | - |
8
|
$0.80 | $2.25 | -100.00% | 0 | $2.45M |
ATHX | Athersys | - |
6
|
$0.00 | $5.50 | 0.00% | 1 | $0.87M |
BLCM | Bellicum Pharmaceuticals | - |
6
|
$0.06 | $5.00 | -100.00% | 0 | $0.77M |
CFRX.Q | ContraFect |
5
|
$0.02 | $7.00 | 34900.00% | 0 | $0.32M | |
CALA | Calithera Biosciences | - |
6
|
$0.02 | $7.71 | -100.00% | 1 | $0.10M |
XLRN | Acceleron Pharma | - |
0
|
$179.68 | $177.75 | -100.00% | 0 | $0.00M |
GNCA.Q | Genocea Biosciences | - |
9
|
$0.00 | $6.00 | 0.00% | 0 | $0.00M |
ONCS.Q | OncoSec Medical | - |
7
|
$0.00 | $110.00 | 0.00% | 0 | $0.00M |
AGTC | Beacon Therapeutics (USA) | - |
11
|
$0.39 | $0.37 | -100.00% | 1 | $0.00M |